In recent years, there has been a lot of talk about the semaglutideknown by the trade names Ozempic And Wegovyas a “miracle” drug. Created to manage diabetes and promote weight loss, this drug is showing a range of benefits that go far beyond its initial functions.
A series of new studies has in fact revealed that people who took semaglutide experienced a reduction in mortality from all the causes. Some scientists now hypothesize that this drug may actually fight the aging process.
The drug that could slow down aging
During the 2024 Conference of the European Society of Cardiologythe professor Harlan Krumholz Yale School of Medicine said: “Semaglutide has benefits beyond what we had imagined. It’s not just about preventing heart attacks. These drugs promote overall health. It wouldn’t surprise me if improving people’s health in this way actually slowed the aging process.”
This statement is based on the findings of the Trial Selectinvolving more than 17,600 people aged 45 and over, all of whom were obese or overweight and had cardiovascular disease but no diabetes. Over the course of more than three years, participants were given either semaglutide or a placebo.
The surprising results of the study
The data emerging from the trial are clear: those who took semaglutide recorded a 19% discount of all-cause mortality compared to the placebo group, including deaths from infections and cardiovascular problems. For example, deaths from COVID-19 have been reduced by 33%.
The semaglutide is a GLP-1 agonist, a hormone that regulates the production of insulin in the body. Not only does it effectively manage blood sugar levels, but it also affects appetite and the perception of satiety, making it useful for weight control. However, its effects do not stop there: it has been linked to a reduced risk of dementiato treat diabetic kidney disease and reduce the risk of heart disease.
A versatile drug
The results of these latest studies further demonstrate the broad versatility of semaglutide. Dr. Benjamin Sciricalead author of one of the Select studies, said: “The robust reduction in non-cardiovascular mortality, particularly from infections, was striking. These results reinforce the fact that overweight and obesity increase the risk of death from many causes, which can be modified with therapies such as semaglutide.”
While there are some concerns about side effects, such as the potential link to suicidal thoughts, most current evidence seems to indicate that the semaglutide is actually keeping its promises.
A promising future for semaglutide?
As research continues, semaglutide is emerging as one of the most promising drugs in recent times. If these benefits hold true, it could revolutionize not only the management of chronic diseases such as diabetes and obesity, but also become a weapon against the aging process.
What does the future hold for this drug? Only time and further research will tell.
#Surprising #Discoveries #Semaglutide #AntiAging #Effect
